Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Current Taxes (2022 - 2024)

Arcturus Therapeutics Holdings (ARCT) has disclosed Current Taxes for 2 consecutive years, with $641000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Current Taxes fell 50.5% year-over-year to $641000.0, compared with a TTM value of $641000.0 through Dec 2023, down 50.5%, and an annual FY2023 reading of $641000.0, down 50.5% over the prior year.
  • Current Taxes was $641000.0 for Q4 2023 at Arcturus Therapeutics Holdings, up from $482000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $1.3 million in Q4 2022 and bottomed at $482000.0 in Q3 2023.